{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2017-07-20T15%3A17%3A01.463Z&AnsweringBody.=Department+of+Health+and+Social+Care&max-answer.questionFirstAnswered.=2023-07-19T15%3A05%3A50.113Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2017-07-20T15%3A17%3A01.463Z&AnsweringBody.=Department+of+Health+and+Social+Care&max-answer.questionFirstAnswered.=2023-07-19T15%3A05%3A50.113Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2017-07-20T15%3A17%3A01.463Z&AnsweringBody.=Department+of+Health+and+Social+Care&_metadata=all&max-answer.questionFirstAnswered.=2023-07-19T15%3A05%3A50.113Z", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-answer.questionFirstMinisteriallyCorrected.=2017-07-20T15%3A17%3A01.463Z&AnsweringBody.=Department+of+Health+and+Social+Care&max-answer.questionFirstAnswered.=2023-07-19T15%3A05%3A50.113Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2017-07-20T15%3A17%3A01.463Z&AnsweringBody.=Department+of+Health+and+Social+Care&max-answer.questionFirstAnswered.=2023-07-19T15%3A05%3A50.113Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.questionFirstMinisteriallyCorrected.=2017-07-20T15%3A17%3A01.463Z&AnsweringBody.=Department+of+Health+and+Social+Care&max-answer.questionFirstAnswered.=2023-07-19T15%3A05%3A50.113Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1651487", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1651487/answer", "answerText" : {"_value" : "

The early access to medicines scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need.<\/del><\/p>

Under the scheme, the Medicines and Healthcare products Regulatory Agency (MHRA) will give a scientific opinion on the benefit/risk balance of the medicine, based on the data available when the EAMS submission was made and the EAMS criteria. The MHRA will make an evaluation of products, including drugs such as for brain tumour treatments, once an application is received.<\/del><\/p>

If we do receive an application, it is only made public where an EAMS Scientific Opinion (SO) is awarded. All EAMS SOs are published on the EAMS webpage. All drugs that have previously held an EAMS SO are also published on the EAMS webpage.<\/del><\/p>

The Pharmacy Access Scheme provides additional funding to pharmacies where the next nearest pharmacy is more than a 20-minute walk away. This is calculated as a 0.8-mile walking distance in areas of high deprivation and 1 mile in other areas. In 2021, we agreed updated eligibility criteria and an updated payment model with Community Pharmacy England. To be eligible for the payment, pharmacies must deliver the Community Pharmacist Consultation Service. Quality and opening hours are not included in the eligibility criteria.<\/ins><\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2023-07-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1651487/answer/previousversion/88780", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} } , "questionFirstAnswered" : [{"_value" : "2023-07-19T15:05:50.113Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2023-07-20T15:18:01.373Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-07-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pharmacy: Standards"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what assessment they have made of the level of support available under the Pharmacy Access Scheme; and whether the criteria includes the (1) quality, (2) opening hours, and (3) range of provision, of existing pharmacies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"} ], "uin" : "HL9200"} , {"_about" : "http://data.parliament.uk/resources/1650136", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1650136/answer", "answerText" : {"_value" : "

The Government has no plans.<\/del><\/p>

The Scientific Advisory Committee on Nutrition (SACN) is currently carrying out a scoping review of the evidence on processed foods and health and aims to publish its initial assessment in the summer of 2023. SACN\u2019s scoping review will make a number of research recommendations in this area. This review will also include evaluating\u202fexisting classifications of processed foods, including ultra-processed foods and the NOVA classification.<\/ins><\/p>

SACN is a committee of the Office for Health Improvement and Disparities (OHID) and provides independent scientific advice and risk assessments on nutrition and related health issues. Members of SACN are appointed as independent scientific experts in their field. We are not aware of any plans to agree a definition internationally.<\/ins><\/p>

The Department funds research on health and social care through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health including ultra-processed foods. The usual practice of the NIHR is not to ring-fence funds for expenditure on particular topics.<\/ins><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2023-07-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1650136/answer/previousversion/86576", "answeringMember" : "http://data.parliament.uk/members/4708", "answeringMemberPrinted" : {"_value" : "Lord Bethell"} } , "questionFirstAnswered" : [{"_value" : "2023-07-10T16:22:27.567Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2023-07-13T14:43:31.113Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-07-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Processed Food"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what discussions they are having with (1) UK medical professionals and scientists, and (2) international partners, about (a) developing, and (b) agreeing, internationally recognised definitions of ultra-processed food.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4298", "label" : {"_value" : "Biography information for Baroness Suttie"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Suttie"} ], "uin" : "HL9040"} , {"_about" : "http://data.parliament.uk/resources/1650137", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1650137/answer", "answerText" : {"_value" : "

The Government has no plans.<\/del><\/p>

The Scientific Advisory Committee on Nutrition (SACN) is currently carrying out a scoping review of the evidence on processed foods and health and aims to publish its initial assessment in the summer of 2023. SACN\u2019s scoping review will make a number of research recommendations in this area. This review will also include evaluating\u202fexisting classifications of processed foods, including ultra-processed foods and the NOVA classification.<\/ins><\/p>

SACN is a committee of the Office for Health Improvement and Disparities (OHID) and provides independent scientific advice and risk assessments on nutrition and related health issues. Members of SACN are appointed as independent scientific experts in their field. We are not aware of any plans to agree a definition internationally.<\/ins><\/p>

The Department funds research on health and social care through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health including ultra-processed foods. The usual practice of the NIHR is not to ring-fence funds for expenditure on particular topics.<\/ins><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2023-07-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1650137/answer/previousversion/86577", "answeringMember" : "http://data.parliament.uk/members/4708", "answeringMemberPrinted" : {"_value" : "Lord Bethell"} } , "questionFirstAnswered" : [{"_value" : "2023-07-10T16:22:27.617Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2023-07-20T15:18:27.453Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-07-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Processed Food"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what plans they have to carry out research into the impact of ultra-processed foods on public health outcomes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4298", "label" : {"_value" : "Biography information for Baroness Suttie"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Suttie"} ], "uin" : "HL9041"} , {"_about" : "http://data.parliament.uk/resources/1649604", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1649604/answer", "answerText" : {"_value" : "

NHS providers determine how many seasonal flu vaccines to buy each year based on their local populations, eligible cohorts and uptake ambitions for the NHS programme as outlined in the annual flu system letter. The letter, published on the 25 May 2023, is based on the advice of the Joint Committee on Vaccination and Immunisation (JCVI) who review the latest evidence on flu vaccines and advise on the type of vaccine to be offered to different age groups and on which vaccines should be prioritised for various at-risk groups.<\/p>

General Practitioners and community pharmacists are responsible for ordering their own flu vaccines for the adult population from suppliers. These are then used to deliver the national flu vaccination programme, with deliveries phased through the season to help mitigate against risks of wastage, cold chain failure and to adequately cover the peaks and flows of local demand. In addition, Hospital Trusts are commissioned at local discretion, to further support delivery of the national flu vaccination programme, for example to women who are pregnant, long stay in-patients and those accessing outpatients' services.<\/p>

School Age Immunisation Services (SAIS) are commissioned regionally to deliver the school aged influenza programme in line with the annual flu system letter and amendment published on the July 3, 2023. The school age programme for 2023/24 includes primary school aged children from Reception to Year 6 and secondary school-aged children in Years 7, 8, 9, 10 and 11. Vaccines for the children\u2019s programme are procured nationally with SAIS<\/p>

TARGET DATE 11/07/2023<\/del><\/p>

providers responsible for drawing down their own vaccines according to their schedules, capacity and demand, with deliveries phased through the season to help mitigate against risks of wastage and cold chain failure.<\/p>

For in detail seasonal influenza percentage uptake delivered by (a) Community Pharmacies, (b) General Practice, (c) other providers please see page 41 and 42 of the following link: Seasonal influenza vaccine uptake in GP patients: winter season 2022 to 2023 (publishing.service.gov.uk)<\/del><\/p>

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1164871/GP-patients-flu-annual-report-2022-2023.pdf<\/a><\/ins><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2023-07-11", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1649604/answer/previousversion/87011", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} } , "questionFirstAnswered" : [{"_value" : "2023-07-11T16:13:38.79Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2023-07-12T08:23:43.733Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-07-03", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Influenza: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the percentage of seasonal flu vaccinations which can be delivered by (a) Community Pharmacies, (b) General Practice, (c) other providers.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/481", "label" : {"_value" : "Biography information for Sir George Howarth"} } , "tablingMemberConstituency" : {"_value" : "Knowsley"} , "tablingMemberPrinted" : [{"_value" : "Sir George Howarth"} ], "uin" : "192008"} , {"_about" : "http://data.parliament.uk/resources/1648716", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1648716/answer", "answerText" : {"_value" : "

All National screening programmes are introduced based on recommendations made by the UK National Screening Committee (UK NSC). The UK NSC assesses and evaluates the evidence to offer screening when it will offer more good than harm. Screening age ranges are selected based on the range where the evidence supports that balance.<\/p>

The National Health Service breast screening programme invites eligible women to be screened every three years from the age of 50 up to their 71st birthday.<\/p>

The NHS bowel screening programme invited men and women every two years from ages 60 to 74 years old. The programme is expanding to make it available to everyone aged 50 to 59 years old. This is happening gradually over four years and started in April 2021.<\/p>

The NHS cervical screening programme invites people with a cervix between the ages of 25 and 49 for screening every three years, whilst people aged 50 to 64 receive an invitation every five years.<\/p>

The NHS abdominal aortic aneurysm screening programme offers men a screening the year they turn 65.<\/p>

The NHS diabetic eye screening programme is offered to anyone with diabetes who is 12 years old or over. Those eligible are invited for an annual screening.<\/p>

The NHS targeted lung cancer screening programme that has been recently announced will invite people aged 55 to 74 identified as being at high risk of lung cancer for screening.<\/p>

For antenatal screening programmes, pregnant women are invited early for screening once the pregnancy has been confirmed. This includes the NHS foetal anomaly screening programme and NHS infectious diseases in pregnancy.<\/p>

Screening for newborns is also offered early at a time when conditions can be detected and where early treatment can improve the baby\u2019s health and prevent severe disability or even death. Newborn screening programmes include the NHS newborn blood spot screening programme, the NHS newborn hearing screening programme, the NHS newborn and infant physical examination screening programme and the NHS sickle cell and thalassaemia screening programme.<\/ins><\/p><\/ins><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2023-07-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1648716/answer/previousversion/87138", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} } , "questionFirstAnswered" : [{"_value" : "2023-07-12T13:22:33.057Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2023-07-20T15:18:13.777Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-06-28", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Screening: Age"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what are the age limits on each of the NHS screening programmes and the justification for each limit.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL8877"} , {"_about" : "http://data.parliament.uk/resources/1644491", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1644491/answer", "answerText" : {"_value" : "

\u2018The National Health Service (Integrated Care Boards: Responsibilities) Regulations 2022\u2019<\/del> The Health and Care Act 2022 (Consequential and Related Amendments and Transitional Provisions) Regulations 2022 SI/634<\/ins> has made consequential amendments to regulation 2 of the NHS Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, replacing references to Clinical Commissioning Groups with integrated care boards (ICBs). ICBs are now the statutory bodies responsible for patient rights.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2023-06-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1644491/answer/previousversion/84191", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} } , "questionFirstAnswered" : [{"_value" : "2023-06-27T16:18:31.383Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2023-07-26T13:28:18.183Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-06-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Integrated Care boards"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what is their policy justification for deciding not to define an integrated care board as a \u201crelevant body\u201d in regulation 2 of the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the effect that a range of patient rights formerly imposed on clinical commissioning groups are not now imposed on integrated care boards.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL8440"} , {"_about" : "http://data.parliament.uk/resources/1639305", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1639305/answer", "answerText" : {"_value" : "

The Department has not made a specific assessment of the potential merits of introducing FibroScans in primary care to improve early diagnosis of non-alcohol related fatty liver disease. However, a practice has clinical discretion to decide if a FibroScan is necessary and appropriate for a patient and can either provide directly or through a provider, typically a hospital out-patient appointment.<\/p>

In addition, NHS England have confirmed they have begun to assess the introduction of FibroScans through Community Diagnostic Centres. £2.3 billion is being spent to increase the number of Community Diagnostic Centres by March 2025, these centres will offer a range of services, with some providing services to support liver diagnosis . This will boost capacity to diagnose liver disease and improve earlier diagnosis and health outcomes.<\/ins><\/p><\/ins><\/p>

In addition, NHS England have confirmed they have begun to assess the introduction of FibroScans through Community Diagnostic Centres. £2.3 billion is being spent to increase the number of Centres diagnosing liver disease to at least 100 sites by March 2025. This will boost diagnostic capacity to diagnose liver disease and improve earlier diagnosis and health outcomes.<\/del><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"} } , "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"} , "answeringMemberPrinted" : {"_value" : "Helen Whately"} , "dateOfAnswer" : {"_value" : "2023-05-30", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1639305/answer/previousversion/77366", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"} } , "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"} , "answeringMemberPrinted" : {"_value" : "Helen Whately"} } , "questionFirstAnswered" : [{"_value" : "2023-05-30T14:08:29.717Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2023-07-11T15:48:09.877Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-05-22", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Liver Diseases: Screening"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of introducing FibroScans in primary care to improve early diagnosis of non-alcohol related fatty liver disease.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4754", "label" : {"_value" : "Biography information for Peter Gibson"} } , "tablingMemberConstituency" : {"_value" : "Darlington"} , "tablingMemberPrinted" : [{"_value" : "Peter Gibson"} ], "uin" : "186182"} , {"_about" : "http://data.parliament.uk/resources/1608150", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1608150/answer", "answerText" : {"_value" : "

NHS Blood and Transplant produces literature relating to donations in various languages including Welsh, Bengali, Gujarati, Hindi, Punjabi, Tamil, Urdu, Arabic, Somali, Polish, Romanian, French, Cantonese, Mandarin, Hebrew,<\/del> and Yiddish.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"} } , "answeringMemberConstituency" : {"_value" : "Harborough"} , "answeringMemberPrinted" : {"_value" : "Neil O'Brien"} , "dateOfAnswer" : {"_value" : "2023-04-17", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1608150/answer/previousversion/67678", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"} } , "answeringMemberConstituency" : {"_value" : "Harborough"} , "answeringMemberPrinted" : {"_value" : "Neil O'Brien"} } , "questionFirstAnswered" : [{"_value" : "2023-04-17T08:18:03.4Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2023-05-03T08:29:27.01Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-03-28", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Blood and Organs: Donors"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 March 2023 to Question 170758 on Blood: Ethnic Groups, which languages literature relating to NHS blood and transplant donations is available in.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4811", "label" : {"_value" : "Biography information for Navendu Mishra"} } , "tablingMemberConstituency" : {"_value" : "Stockport"} , "tablingMemberPrinted" : [{"_value" : "Navendu Mishra"} ], "uin" : "175672"} , {"_about" : "http://data.parliament.uk/resources/1601933", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1601933/answer", "answerText" : {"_value" : "

The Department has published its Health Infrastructure Plan in September 2019 that sets out the Government\u2019s strategy and priorities for investing in the National Health Service estate, including in cancer centres. We are at present working on an update to this strategy through to 2030.<\/del><\/p>

The Department-funded National Institute for Health and Care Research (NIHR) invests in research, clinical expertise, specialist facilities, workforce and support services across a range of clinical areas, including brain tumour research.<\/ins><\/p>

NIHR has recently announced the outcome of the Biomedical Research Centre (BRC) competition in which six BRCs have been funded to support brain tumour research. The NIHR BRCs works in partnership with other research centres such as the CRUK Brain Tumour Centre of Excellence to collect samples for research purposes as well as local and national sample storage facilities to support research into brain tumours.<\/ins><\/p><\/ins><\/p>

Currently, we do not have a national capital programme strictly dedicated to cancer centres. However, there are several programmes, including the Targeted Investment Fund, the New Hospital Programme and the Hospital Upgrades Programme, that are funding upgrades to existing cancer centres. These schemes are assessed on a case-by-case basis.<\/del><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"} } , "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"} , "answeringMemberPrinted" : {"_value" : "Helen Whately"} , "dateOfAnswer" : {"_value" : "2023-03-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1601933/answer/previousversion/61183", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"} } , "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"} , "answeringMemberPrinted" : {"_value" : "Helen Whately"} } , "questionFirstAnswered" : [{"_value" : "2023-03-13T11:09:49.25Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2023-03-14T10:37:25.61Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-03-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Brain: Tumours"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of developing a strategic plan for the (a) funding and (b) other resourcing of (i) discovery, (ii) translational and (iii) clinical research into brain tumours.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4082", "label" : {"_value" : "Biography information for Lisa Nandy"} } , "tablingMemberConstituency" : {"_value" : "Wigan"} , "tablingMemberPrinted" : [{"_value" : "Lisa Nandy"} ], "uin" : "160266"} , {"_about" : "http://data.parliament.uk/resources/1601411", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1601411/answer", "answerText" : {"_value" : "

Suggested reply<\/strong><\/p>

The following table shows the expenditure on consultancy on external consultants in the financial years 2019/20 to 2021/22. Expenditure values for 2022/23 are not yet available. The Department does not hold the detail behind the expenditure.<\/p>

Organisation<\/p><\/td>

Expenditure on consultancy (£ million)<\/p><\/td><\/tr>

2019/20<\/p><\/td>

2020/21<\/p><\/td>

2021/22<\/p><\/td><\/tr>

Medicines and Healthcare products Regulatory Agency (MHRA)<\/p><\/td>

Not available<\/del> 0.3<\/ins><\/p><\/td>

Not available<\/del> 0.8<\/ins><\/p><\/td>

Not available<\/del> 6.4<\/ins><\/p><\/td><\/tr>

UK Health Security Agency (UKHSA)<\/p><\/td>

Not applicable<\/p><\/td>

Not applicable<\/p><\/td>

10.0<\/p><\/td><\/tr>

NHS England - Group<\/p><\/td>

45.8<\/p><\/td>

51.6<\/p><\/td>

75.8<\/p><\/td><\/tr>

NHS Digital<\/p><\/td>

1.4<\/p><\/td>

0.9<\/p><\/td>

0.3<\/p><\/td><\/tr><\/tbody><\/table>

<\/p>

Note:<\/p>

  1. The definition for consultancy is in line with HM Treasury Guidance<\/li>
  2. The Office for National Statistics re-categorised MHRA as falling within the Departmental Group from April 2022. In years 2019/20, 2020/21 and 2021/22 this body was not incorporated into the Department\u2019s accounting boundary and, therefore, the Department does not hold requested data.<\/li>
  3. UKHSA was formed in April 2021 and became fully operational in October 2021.<\/li><\/ol>

    Source:<\/p>

    UK Health Security Agency Annual Report and Accounts 2021/22.<\/p>

    NHS Commissioning Board Annual Report and Accounts 2019/20, 2020/21 and 2021/22. Expenditure for the NHSE Group including Commissioning Support Units and Clinical Commissioning Groups (CCGs).<\/p>

    NHS Digital Annual Report and Accounts 2019/20, 2020/21 and 2021/22.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-03-30", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1601411/answer/previousversion/66497", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} } , "questionFirstAnswered" : [{"_value" : "2023-03-30T14:37:21.307Z", "_datatype" : "dateTime"} ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2023-04-04T11:16:39.12Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-03-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Consultants: Expenditure"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what the cost to the public purse was of spending on external consultants by (a) the Medicines and Healthcare products Regulatory Agency, (b) the UK Health Security Agency, (c) NHS England, and (d) NHS Digital in (i) 2020, (ii) 2021 and (iii) 2022; and whether any of that spending related to the preparation of funding bids to (A) his Department and (B) HM Treasury.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1536", "label" : {"_value" : "Biography information for Emily Thornberry"} } , "tablingMemberConstituency" : {"_value" : "Islington South and Finsbury"} , "tablingMemberPrinted" : [{"_value" : "Emily Thornberry"} ], "uin" : "158842"} ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&min-answer.questionFirstMinisteriallyCorrected.=2017-07-20T15%3A17%3A01.463Z&AnsweringBody.=Department+of+Health+and+Social+Care&max-answer.questionFirstAnswered.=2023-07-19T15%3A05%3A50.113Z", "page" : 0, "startIndex" : 1, "totalResults" : 171, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }